Global Antihypertensive Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 21-Dec-2018
No. of pages: 132

Scope of the Report:

This report focuses on the Antihypertensive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.

Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.

-

The worldwide market for Antihypertensive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Pfizer

- Novartis

- Sanofi

- Merck

- Boehringer Ingelheim

- Lupin

- Johnson & Johnson

- Astra Zeneca

- Daiichi Sankyo

- Ranbaxy

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Diuretics 

- Angiotensin receptor blockers (ARBs) 

- Angiotensin converting enzyme (ACE) inhibitors 

- Beta blockers

- Alpha blockers

- Calcium channel blockers 

- Renin inhibitors

- Vasodilators 

Market Segment by Applications, can be divided into

- Hosptial

- Clinic

- Home

There are 15 Chapters to deeply display the global Antihypertensive market.

Chapter 1, to describe Antihypertensive Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antihypertensive, with sales, revenue, and price of Antihypertensive, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antihypertensive, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antihypertensive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Antihypertensive Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Diuretics 
1.2.2 Angiotensin receptor blockers (ARBs) 
1.2.3 Angiotensin converting enzyme (ACE) inhibitors 
1.2.4 Beta blockers
1.2.5 Alpha blockers
1.2.6 Calcium channel blockers 
1.2.7 Renin inhibitors
1.2.8 Vasodilators 
1.3 Market Analysis by Applications
1.3.1 Hosptial
1.3.2 Clinic
1.3.3 Home
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Antihypertensive Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Antihypertensive Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Antihypertensive Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Antihypertensive Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Antihypertensive Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lupin
2.6.1 Business Overview
2.6.2 Antihypertensive Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Antihypertensive Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Astra Zeneca
2.8.1 Business Overview
2.8.2 Antihypertensive Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Daiichi Sankyo
2.9.1 Business Overview
2.9.2 Antihypertensive Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ranbaxy
2.10.1 Business Overview
2.10.2 Antihypertensive Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antihypertensive Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Manufacturer Market Share in 2017
3.3.2 Top 6 Antihypertensive Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antihypertensive Market Analysis by Regions
4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antihypertensive Revenue and Market Share by Regions (2013-2018)
4.2 North America Antihypertensive Sales and Growth Rate (2013-2018)
4.3 Europe Antihypertensive Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antihypertensive Sales and Growth Rate (2013-2018)
4.5 South America Antihypertensive Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antihypertensive Sales and Growth Rate (2013-2018)
5 North America Antihypertensive by Countries
5.1 North America Antihypertensive Sales, Revenue and Market Share by Countries
5.1.1 North America Antihypertensive Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antihypertensive Revenue and Market Share by Countries (2013-2018)
5.2 United States Antihypertensive Sales and Growth Rate (2013-2018)
5.3 Canada Antihypertensive Sales and Growth Rate (2013-2018)
5.4 Mexico Antihypertensive Sales and Growth Rate (2013-2018)
6 Europe Antihypertensive by Countries
6.1 Europe Antihypertensive Sales, Revenue and Market Share by Countries
6.1.1 Europe Antihypertensive Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antihypertensive Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antihypertensive Sales and Growth Rate (2013-2018)
6.3 UK Antihypertensive Sales and Growth Rate (2013-2018)
6.4 France Antihypertensive Sales and Growth Rate (2013-2018)
6.5 Russia Antihypertensive Sales and Growth Rate (2013-2018)
6.6 Italy Antihypertensive Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antihypertensive by Countries
7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antihypertensive Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antihypertensive Revenue and Market Share by Countries (2013-2018)
7.2 China Antihypertensive Sales and Growth Rate (2013-2018)
7.3 Japan Antihypertensive Sales and Growth Rate (2013-2018)
7.4 Korea Antihypertensive Sales and Growth Rate (2013-2018)
7.5 India Antihypertensive Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
8 South America Antihypertensive by Countries
8.1 South America Antihypertensive Sales, Revenue and Market Share by Countries
8.1.1 South America Antihypertensive Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antihypertensive Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antihypertensive Sales and Growth Rate (2013-2018)
8.3 Argentina Antihypertensive Sales and Growth Rate (2013-2018)
8.4 Colombia Antihypertensive Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antihypertensive by Countries
9.1 Middle East and Africa Antihypertensive Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antihypertensive Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antihypertensive Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
9.3 UAE Antihypertensive Sales and Growth Rate (2013-2018)
9.4 Egypt Antihypertensive Sales and Growth Rate (2013-2018)
9.5 Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
9.6 South Africa Antihypertensive Sales and Growth Rate (2013-2018)
10 Global Antihypertensive Market Segment by Type
10.1 Global Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antihypertensive Sales and Market Share by Type (2013-2018)
10.1.2 Global Antihypertensive Revenue and Market Share by Type (2013-2018)
10.2 Diuretics  Sales Growth and Price
10.2.1 Global Diuretics  Sales Growth (2013-2018)
10.2.2 Global Diuretics  Price (2013-2018)
10.3 Angiotensin receptor blockers (ARBs)  Sales Growth and Price
10.3.1 Global Angiotensin receptor blockers (ARBs)  Sales Growth (2013-2018)
10.3.2 Global Angiotensin receptor blockers (ARBs)  Price (2013-2018)
10.4 Angiotensin converting enzyme (ACE) inhibitors  Sales Growth and Price
10.4.1 Global Angiotensin converting enzyme (ACE) inhibitors  Sales Growth (2013-2018)
10.4.2 Global Angiotensin converting enzyme (ACE) inhibitors  Price (2013-2018)
10.5 Beta blockers Sales Growth and Price
10.5.1 Global Beta blockers Sales Growth (2013-2018)
10.5.2 Global Beta blockers Price (2013-2018)
10.6 Alpha blockers Sales Growth and Price
10.6.1 Global Alpha blockers Sales Growth (2013-2018)
10.6.2 Global Alpha blockers Price (2013-2018)
10.7 Calcium channel blockers  Sales Growth and Price
10.7.1 Global Calcium channel blockers  Sales Growth (2013-2018)
10.7.2 Global Calcium channel blockers  Price (2013-2018)
10.8 Renin inhibitors Sales Growth and Price
10.8.1 Global Renin inhibitors Sales Growth (2013-2018)
10.8.2 Global Renin inhibitors Price (2013-2018)
10.9 Vasodilators  Sales Growth and Price
10.9.1 Global Vasodilators  Sales Growth (2013-2018)
10.9.2 Global Vasodilators  Price (2013-2018)
11 Global Antihypertensive Market Segment by Application
11.1 Global Antihypertensive Sales Market Share by Application (2013-2018)
11.2 Hosptial Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Home Sales Growth (2013-2018)
12 Antihypertensive Market Forecast (2018-2023)
12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
12.2 Antihypertensive Market Forecast by Regions (2018-2023)
12.2.1 North America Antihypertensive Market Forecast (2018-2023)
12.2.2 Europe Antihypertensive Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antihypertensive Market Forecast (2018-2023)
12.2.4 South America Antihypertensive Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antihypertensive Market Forecast (2018-2023)
12.3 Antihypertensive Market Forecast by Type (2018-2023)
12.3.1 Global Antihypertensive Sales Forecast by Type (2018-2023)
12.3.2 Global Antihypertensive Market Share Forecast by Type (2018-2023)
12.4 Antihypertensive Market Forecast by Application (2018-2023)
12.4.1 Global Antihypertensive Sales Forecast by Application (2018-2023)
12.4.2 Global Antihypertensive Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Antihypertensive Picture
Table Product Specifications of Antihypertensive
Figure Global Sales Market Share of Antihypertensive by Types in 2017
Table Antihypertensive Types for Major Manufacturers
Figure Diuretics  Picture
Figure Angiotensin receptor blockers (ARBs)  Picture
Figure Angiotensin converting enzyme (ACE) inhibitors  Picture
Figure Beta blockers Picture
Figure Alpha blockers Picture
Figure Calcium channel blockers  Picture
Figure Renin inhibitors Picture
Figure Vasodilators  Picture
Figure Antihypertensive Sales Market Share by Applications in 2017
Figure Hosptial Picture
Figure Clinic Picture
Figure Home Picture
Figure United States Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure France Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure China Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure India Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antihypertensive Type and Applications
Table Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Antihypertensive Type and Applications
Table Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Antihypertensive Type and Applications
Table Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antihypertensive Type and Applications
Table Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Antihypertensive Type and Applications
Table Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Antihypertensive Type and Applications
Table Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Antihypertensive Type and Applications
Table Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Antihypertensive Type and Applications
Table Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Antihypertensive Type and Applications
Table Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ranbaxy Basic Information, Manufacturing Base and Competitors
Table Ranbaxy Antihypertensive Type and Applications
Table Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antihypertensive Sales by Manufacturer (2016-2017)
Figure Global Antihypertensive Sales Market Share by Manufacturer in 2016
Figure Global Antihypertensive Sales Market Share by Manufacturer in 2017
Table Global Antihypertensive Revenue by Manufacturer (2016-2017)
Figure Global Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure Global Antihypertensive Revenue Market Share by Manufacturer in 2017
Figure Top 3 Antihypertensive Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antihypertensive Manufacturer (Revenue) Market Share in 2017
Figure Global Antihypertensive Sales and Growth Rate (2013-2018)
Figure Global Antihypertensive Revenue and Growth Rate (2013-2018)
Table Global Antihypertensive Sales by Regions (2013-2018)
Table Global Antihypertensive Sales Market Share by Regions (2013-2018)
Table Global Antihypertensive Revenue by Regions (2013-2018)
Figure Global Antihypertensive Revenue Market Share by Regions in 2013
Figure Global Antihypertensive Revenue Market Share by Regions in 2017
Figure North America Antihypertensive Sales and Growth Rate (2013-2018)
Figure Europe Antihypertensive Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antihypertensive Sales and Growth Rate (2013-2018)
Figure South America Antihypertensive Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antihypertensive Sales and Growth Rate (2013-2018)
Figure North America Antihypertensive Revenue and Growth Rate (2013-2018)
Table North America Antihypertensive Sales by Countries (2013-2018)
Table North America Antihypertensive Sales Market Share by Countries (2013-2018)
Figure North America Antihypertensive Sales Market Share by Countries in 2013
Figure North America Antihypertensive Sales Market Share by Countries in 2017
Table North America Antihypertensive Revenue by Countries (2013-2018)
Table North America Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure North America Antihypertensive Revenue Market Share by Countries in 2013
Figure North America Antihypertensive Revenue Market Share by Countries in 2017
Figure United States Antihypertensive Sales and Growth Rate (2013-2018)
Figure Canada Antihypertensive Sales and Growth Rate (2013-2018)
Figure Mexico Antihypertensive Sales and Growth Rate (2013-2018)
Figure Europe Antihypertensive Revenue and Growth Rate (2013-2018)
Table Europe Antihypertensive Sales by Countries (2013-2018)
Table Europe Antihypertensive Sales Market Share by Countries (2013-2018)
Table Europe Antihypertensive Revenue by Countries (2013-2018)
Figure Europe Antihypertensive Revenue Market Share by Countries in 2016
Figure Europe Antihypertensive Revenue Market Share by Countries in 2017
Figure Germany Antihypertensive Sales and Growth Rate (2013-2018)
Figure UK Antihypertensive Sales and Growth Rate (2013-2018)
Figure France Antihypertensive Sales and Growth Rate (2013-2018)
Figure Russia Antihypertensive Sales and Growth Rate (2013-2018)
Figure Italy Antihypertensive Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antihypertensive Sales by Countries (2013-2018)
Table Asia-Pacific Antihypertensive Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antihypertensive Sales Market Share by Countries 2017
Table Asia-Pacific Antihypertensive Revenue by Countries (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue Market Share by Countries 2017
Figure China Antihypertensive Sales and Growth Rate (2013-2018)
Figure Japan Antihypertensive Sales and Growth Rate (2013-2018)
Figure Korea Antihypertensive Sales and Growth Rate (2013-2018)
Figure India Antihypertensive Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
Figure South America Antihypertensive Revenue and Growth Rate (2013-2018)
Table South America Antihypertensive Sales by Countries (2013-2018)
Table South America Antihypertensive Sales Market Share by Countries (2013-2018)
Figure South America Antihypertensive Sales Market Share by Countries in 2017
Table South America Antihypertensive Revenue by Countries (2013-2018)
Table South America Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure South America Antihypertensive Revenue Market Share by Countries in 2017
Figure Brazil Antihypertensive Sales and Growth Rate (2013-2018)
Figure Argentina Antihypertensive Sales and Growth Rate (2013-2018)
Figure Colombia Antihypertensive Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antihypertensive Sales by Countries (2013-2018)
Table Middle East and Africa Antihypertensive Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antihypertensive Sales Market Share by Countries in 2017
Table Middle East and Africa Antihypertensive Revenue by Countries (2013-2018)
Table Middle East and Africa Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
Figure UAE Antihypertensive Sales and Growth Rate (2013-2018)
Figure Egypt Antihypertensive Sales and Growth Rate (2013-2018)
Figure Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
Figure South Africa Antihypertensive Sales and Growth Rate (2013-2018)
Table Global Antihypertensive Sales by Type (2013-2018)
Table Global Antihypertensive Sales Share by Type (2013-2018)
Table Global Antihypertensive Revenue by Type (2013-2018)
Table Global Antihypertensive Revenue Share by Type (2013-2018)
Figure Global Diuretics  Sales Growth (2013-2018)
Figure Global Diuretics  Price (2013-2018)
Figure Global Angiotensin receptor blockers (ARBs)  Sales Growth (2013-2018)
Figure Global Angiotensin receptor blockers (ARBs)  Price (2013-2018)
Figure Global Angiotensin converting enzyme (ACE) inhibitors  Sales Growth (2013-2018)
Figure Global Angiotensin converting enzyme (ACE) inhibitors  Price (2013-2018)
Figure Global Beta blockers Sales Growth (2013-2018)
Figure Global Beta blockers Price (2013-2018)
Figure Global Alpha blockers Sales Growth (2013-2018)
Figure Global Alpha blockers Price (2013-2018)
Figure Global Calcium channel blockers  Sales Growth (2013-2018)
Figure Global Calcium channel blockers  Price (2013-2018)
Figure Global Renin inhibitors Sales Growth (2013-2018)
Figure Global Renin inhibitors Price (2013-2018)
Figure Global Vasodilators  Sales Growth (2013-2018)
Figure Global Vasodilators  Price (2013-2018)
Table Global Antihypertensive Sales by Application (2013-2018)
Table Global Antihypertensive Sales Share by Application (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Home Sales Growth (2013-2018)
Figure Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
Table Global Antihypertensive Sales Forecast by Regions (2018-2023)
Table Global Antihypertensive Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antihypertensive Market Forecast (2018-2023)
Figure Europe Sales Antihypertensive Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antihypertensive Market Forecast (2018-2023)
Figure South America Sales Antihypertensive Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antihypertensive Market Forecast (2018-2023)
Table Global Antihypertensive Sales Forecast by Type (2018-2023)
Table Global Antihypertensive Market Share Forecast by Type (2018-2023)
Table Global Antihypertensive Sales Forecast by Application (2018-2023)
Table Global Antihypertensive Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global HPQ & Silica for Pharmaceutical Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 116
    Scope of the Report: The worldwide market for HPQ & Silica for Pharmaceutical is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the HPQ & Silica for Pharmaceutical in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based o......
  • Global Non-animal Softgel Capsules Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 121
    Scope of the Report: The worldwide market for Non-animal Softgel Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Non-animal Softgel Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufa......
  • Global Oil Softgel Capsules Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 123
    Scope of the Report: The worldwide market for Oil Softgel Capsules is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Oil Softgel Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regio......
  • Global Betamethasone-21-Acetate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Jan-2019        Price: US 3480 Onwards        Pages: 138
    Scope of the Report: The worldwide market for Betamethasone-21-Acetate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Betamethasone-21-Acetate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs